BIOS

8VC is a Silicon-Valley based technology investment firm investing in visionary teams and backing industry-transforming companies, currently managing $3.5bn in AUM. About one third of their current fund is dedicated towards the BioIT space. 8VC’s portfolio represents a large early crop of now next gen biotech unicorns including but not limited to Orca Bio, Synthego, Resilience, and Lyell Immunopha...

Adam Seabrook is a Principal in B Capital’s Los Angeles office, where he makes investments in Healthcare and Digital Health. Adam serves as Board Member/Board Observer to Evidation Health, SilverCloud Health, Bright.md, Notable Labs and Atomwise. Prior to joining B Capital, Adam worked at Hyde Park Angels, one of the largest angel networks in the US, while pursuing his MBA at the University of Chi...

Mark Pulido is a 5 time CEO & industry veteran with 4+ decades of leadership experience spanning Health IT, Health Services, Big Pharma, Diagnostics, Private Equity, & Venture Back Startups. He is the former President & CEO @ ABILITY, a national leader in cloud-based solutions for the healthcare provider marketplace acquired for $1.2B by Inovalon in 2018 - where he currently serves on...

Mark Pulido is a 5 time CEO & industry veteran with 4+ decades of leadership experience spanning Health IT, Health Services, Big Pharma, Diagnostics, Private Equity, & Venture Back Startups. He is the former President & CEO @ ABILITY, a national leader in cloud-based solutions for the healthcare provider marketplace acquired for $1.2B by Inovalon in 2018 - where he currently serves on...

Vasudev Bailey, PhD, is a Senior Partner @ ARTIS Ventures where he focuses on investing in novel and breakthrough health and life sciences companies. He is an investor in companies including Eko, Unnatural Products, Aether, IDbyDNA, Freenome, Climax Foods, Lemonaid Health, and board member at Association for Women in Sciences (AWIS), Johns Hopkins Biomedical Engineering, and The Trevor Project. He...

Seth Bannon is a Founding Partner @ Fifty Years, a seed fund that backs entrepreneurs solving the world's biggest problems with technology. Seth has seeded a range of startups shaping the world for the better — companies like  Memphis Meats (culturing meat to eat), Solugen (engineering enzymes to produce industrial chemicals sustainably), and Astranis (small satellites to cover the earth with...

Adam D’Augelli is a Partner @ True Ventures, a Silicon Valley-based venture capital firm founded in 2005 that invests in early-stage technology startups. At True, Adam has led the firm’s investments in Pendulum Therapeutics, Deep Genomics, InterVenn Biosciences, and more.  Prior to True, Adam ran Perfect Wave Records, a small donation-based record label in the Southeast and taught “Digital Fr...

Nan Li is a Managing Director @ Obvious Ventures, where he invests in companies solving the world’s biggest problems in sustainable systems, healthy living, and people power. At Obvious, his investments have included LabGenius, Recursion Pharmaceuticals, Darwin AI, Octave Health, Zymergen, and Planet. Prior to joining Obvious, Nan has had a mix of technology, investing, and entrepreneurship experi...

Jessica Chao is the Director of the Clinical Innovation Center at UCSF, where she oversees operations and leads partnerships with industry and academia. She is an investor at Iterative VC and has over 15 years of experience as an operator in health services and med tech management. Previously, she has led product design in various San Francisco startups and co-founded Healtho, a consumer heal...

Tony Kulesa is a Co-founder @ Petri , an accelerator in Boston that backs companies developing new biotech applications and technologies in healthcare, food, industrial chemicals, and new materials. Co-founded and funded by Pillar, a venture firm co-founded by the CEOs of Cytyc, Ginkgo Bioworks, Iora Health, and 22 Boston companies, Petri draws on the resources of one of the strongest biotech ecos...

Robert Pearl is the former CEO @ The Permanente Medical Group (1999-2017), the nation’s largest medical group, and former president of The Mid-Atlantic Permanente Medical Group (2009-2017). In these roles he led 10,000 physicians, 38,000 staff and was responsible for the nationally recognized medical care of 5 million Kaiser Permanente members on the west and east coasts. Dr. Pearl is nationally r...

Rob Chess is a successful and esteemed serial biotech entrepreneur and executive. His resume is incredibly long and impressive. He is the Chairman of Nektar Therapeutics (NASDAQ: NKTR), a multi-billion dollar market cap company, where he was previously President and CEO. He is co-founder and Board member (until very recently the Chairman) of Biota Technologies, which uses DNA sequencing to optimiz...

Ian Tong is Chief Medical Officer @ Doctor On Demand. He is also currently Clinical Assistant Professor (Affiliated) at Stanford University Medical School. Ian has spent his career working to improve access to high quality care and brings this dedication to his work at Doctor On Demand. Prior to joining Doctor On Demand, Ian held several medical leadership roles. He served as Stanford Internal Med...

BIOS Podcast brings together cutting-edge insights from Life Science industry leaders at the forefront innovation. Join us in hearing from Founders, Investors, Professors, & Pharma operating at the intersection of Technology & Biology. By Alix Ventures: Driving Patient Impact - Supporting early stage Life Science startups engineering biology to drive radical advances in human health. Learn...